KEYSTEP-008: Pembrolizumab (pembro)-based combinations for microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC).
Thierry Andre, Filippo Pietrantonio, S. Yalcin, Joong Bae Ahn et autres
0 citationsJournal of Clinical Oncology